Arthrem clinical trial results show anti-inflammatory properties.

Dietary Supplement Reduces Osteoarthritis Pain

OSTEOARTHRITIS IS RANKED AMONG THE TOP 10 MOST DISABLING DISEASES, AFFECTING APPROXIMATELY 10% OF MEN AND 20% OF WOMEN OVER THE AGE OF 60. COMMON SYMPTOMS ARE PAIN, STIFFNESS AND REDUCED MOBILITY. MANY LIVING WITH OSTEOARTHRITIS EXPERIENCE A REDUCTION IN QUALITY OF LIFE, WITH 80% OF SUFFERERS HAVING LIMITED MOVEMENT AND 25% UNABLE TO PERFORM THEIR MAJOR DAILY ACTIVITIES. 

There is no cure for Osteoarthritis, and many patients find they have few options for managing their daily symptoms. Conventional medicines which are frequently used to relieve joint pain most commonly include analgesics (e.g. acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs; e.g. ibuprofen). While these medicines are effective at reducing pain, they are not recommended for long-term use because of the potential for adverse side effects. Many existing complementary therapies and dietary supplements for Osteoarthritis lack convincing evidence proving their effectiveness and safety. That’s why many patients with Osteoarthritis seek natural alternatives and complementary therapies such as Arthrem®.

Published results of a 12-week randomised controlled clinical trial on Arthrem, a natural dietary supplement developed and manufactured by New Zealand company Promisia, show that participants with Osteoarthritis of the hip or knee showed significant improvement in their symptoms. The trial was run by Professor Simon Stebbings, a consultant Rheumatologist, and conducted at the Rheumatology Research Unit, Dunedin School of Medicine, University of Otago in New Zealand.

The results showed that Arthrem has potential as an anti-inflammatory/analgesic for Osteoarthritis. In patients taking one Arthrem capsule twice a day, pain and stiffness were significantly reduced and physical function significantly improved. Particularly positive results were observed in a subset of patients with mild to moderate Osteoarthritis (as opposed to severe Osteoarthritis). In this subgroup, the average magnitude of pain after 12 weeks of taking Arthrem was less than half of the value at the start of the study. At this dose the supplement was well-tolerated.

The study used the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale, which is a standardised set of questionnaires that health professionals use to assess symptoms in patients with Osteoarthritis. Additionally, a visual analogue scale (VAS) was used to assess joint pain. In the clinical trial, patients continued taking their usual doses of their regular medications and showed no indication of any drug interactions. Nevertheless, the developer and manufacturer Promisia recommends that patients should check with their healthcare professional before taking any dietary supplement if they are on any prescription medication.*

Arthrem contains a proprietary herbal extract from the plant Artemisia annua. This herb, also known as Qinghaosu, has been part of Chinese traditional medicine for more than 2,000 years. Promisia has also conducted extensive independent laboratory studies. The results of these studies have been published in the Journal of Inflammation Research, and show that Arthrem has potent anti-inflammatory properties.

*For further information or to check whether Arthrem is right for you, check out our FAQs >>